Related Experiment Video
Updated: Sep 20, 2025

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer
Saroor A Patel1,2, Shoko Hirosue1, Paulo Rodrigues1
1MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
Abstract:
Large-scale human genetic data1-3 have shown that cancer mutations display strong tissue-selectivity, but how this selectivity arises remains unclear. Here, using experimental models, functional genomics and analyses of patient samples, we demonstrate that the lineage transcription factor paired box 8 (PAX8) is required for oncogenic signalling by two common genetic alterations that cause clear cell renal cell carcinoma (ccRCC) in humans: the germline variant rs7948643 at 11q13.3 and somatic inactivation of the von Hippel-Lindau tumour suppressor (VHL)4-6. VHL loss, which is observed in about 90% of ccRCCs, can lead to hypoxia-inducible factor 2α (HIF2A) stabilization6,7. We show that HIF2A is preferentially recruited to PAX8-bound transcriptional enhancers, including a pro-tumorigenic cyclin D1 (CCND1) enhancer that is controlled by PAX8 and HIF2A. The ccRCC-protective allele C at rs7948643 inhibits PAX8 binding at this enhancer and downstream activation of CCND1 expression. Co-option of a PAX8-dependent physiological programme that supports the proliferation of normal renal epithelial cells is also required for MYC expression from the ccRCC metastasis-associated amplicons at 8q21.3-q24.3 (ref. 8). These results demonstrate that transcriptional lineage factors are essential for oncogenic signalling and that they mediate tissue-specific cancer risk associated with somatic and inherited genetic variants.
Insights
The lineage transcription factor PAX8 is essential for clear cell renal cell carcinoma (ccRCC) development. It mediates oncogenic signaling for both inherited and somatic mutations, explaining tissue-specific cancer risk.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Cancer mutations exhibit strong tissue-selectivity, but the underlying mechanisms are not fully understood.
- Clear cell renal cell carcinoma (ccRCC) is a common kidney cancer with known genetic drivers.
- The role of lineage transcription factors in tissue-specific cancer development is an active area of research.
Purpose of the Study:
- To investigate the role of the lineage transcription factor paired box 8 (PAX8) in the oncogenic signaling of ccRCC.
- To elucidate how PAX8 mediates tissue-specific cancer risk associated with genetic variants in ccRCC.
- To understand the interplay between PAX8, VHL loss, and HIF2A in ccRCC pathogenesis.
Main Methods:
- Experimental models
- Functional genomics
- Analysis of patient samples
- Chromatin immunoprecipitation assays
- Gene expression analysis
Main Results:
- PAX8 is required for oncogenic signaling in ccRCC, driven by both germline variants (rs7948643) and somatic VHL inactivation.
- Hypoxia-inducible factor 2α (HIF2A) is preferentially recruited to PAX8-bound enhancers, including the CCND1 enhancer.
- The ccRCC-protective allele C at rs7948643 inhibits PAX8 binding and CCND1 expression.
- PAX8-dependent programs are co-opted for MYC expression in ccRCC metastasis.
Conclusions:
- Lineage transcription factors like PAX8 are essential mediators of oncogenic signaling in ccRCC.
- PAX8 plays a critical role in conferring tissue-specific cancer risk for both somatic and inherited genetic variants.
- Understanding PAX8's role provides insights into ccRCC development and potential therapeutic strategies.
More Related Videos
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Regulation of Angiogenesis and Blood Supply
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...